Do you need a prescription for Jakafi?
Valid prescription for Jakafi for an FDA-approved indication is required. Patients insured through Medicare Part D, Medicare Advantage, Medicaid, TRICARE, or a state medical assistance program are not eligible. Free product is offered to eligible patients without any purchase contingency or other obligation.
How can incytecares for Jakafi help me?
IncyteCARES for Jakafi is committed to helping eligible patients get the medicine they need. That’s why we offer certain programs, and may be able to connect you to others, that may help make your out-of-pocket costs more affordable if you qualify. To qualify, you must meet certain eligibility requirements. taking Jakafi.
What are the possible side effects of Jakafi?
Jakafi can cause serious side effects, including: The most common side effects of Jakafi include: low platelet count, low red blood cell counts, bruising, dizziness, headache. These are not all the possible side effects of Jakafi. Ask your pharmacist or healthcare provider for more information.
How do I check my blood count before taking Jakafi?
Your healthcare provider will do a blood test to check your blood counts before you start Jakafi and regularly during your treatment. Your healthcare provider may change your dose of Jakafi or stop your treatment based on the results of your blood tests.
Is Jakafi covered by Medicaid?
Be confirmed as eligible for and enrolled in IncyteCARES for Jakafi. Have commercial prescription drug coverage or a healthcare exchange plan. Patients insured under federal or state government prescription drug programs—including Medicare Part D, Medicare Advantage, Medicaid, or TRICARE—are not eligible.
How do I get Jakafi?
Specialty pharmacies usually handle medicines that require more care or that are prescribed for less common or more complex health conditions. Jakafi is one of many medicines available only through specialty pharmacies. You can't fill your prescription for it at a traditional local pharmacy.
When will there be a generic for Jakafi?
Jakafi was eligible for patent challenges on November 16, 2015. By analyzing the patents and regulatory protections it appears that the earliest date for generic entry will be September 22, 2028.
Who is the manufacturer of Jakafi?
If you have questions about Jakafi® (ruxolitinib) or Incyte, please contact us via IncyteCARES at 1-855-452-5234. Call your Healthcare Professional about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA.
What is the monthly cost of Jakafi?
As a guide, Jakafi tablets 5 mg usually cost $15,400 for 60 tablets. With NiceRx you will pay a flat monthly fee of $49, regardless of the retail price of your medication.
How long are people on Jakafi?
Jakafi is a long-term treatment. Your Healthcare Professional may allow up to 6 months to see if Jakafi is working for you. If you do not see an improvement after 6 months of treatment, your Healthcare Professional may have you stop taking Jakafi.
Is Jakafi a chemo drug?
Jakafi is not chemotherapy. It is a targeted treatment that works to help keep the production of blood cells under control.
Does Jakafi cause weight gain?
Common side effects of Jakafi include: anemia, balance impairment, dizziness, headache, labyrinthitis, meniere's disease, neutropenia, thrombocytopenia, vertigo, and orthostatic dizziness. Other side effects include: weight gain, and flatulence.
What tier drug is Jakafi?
What drug tier is Jakafi typically on? Medicare prescription drug plans typically list Jakafi on Tier 5 of their formulary. Generally, the higher the tier, the more you have to pay for the medication.
Does Jakafi have a black box warning?
While Opzelura is celebrated as the first topical formulation of a JAK inhibitor to enter the market, its approval comes with a classwide black box warning that has been added to oral JAKs about serious infections, death, cancer, heart-related events and blood clots.
When does Jakafi go off patent?
In the United States, "Jakafi is covered by eight patents, which range in expiration from December 12, 2026 (the earliest expiration date) to June 12, 2028 (the latest expiration date)." Compl.
Is ruxolitinib the same as Jakafi?
Low blood counts: Jakafi® (ruxolitinib) may cause low platelet, red blood cell, and white blood cell counts. If you develop bleeding, stop taking Jakafi and call your healthcare provider.
When does jakafi go off patent?
In the United States, "Jakafi is covered by eight patents, which range in expiration from December 12, 2026 (the earliest expiration date) to June 12, 2028 (the latest expiration date)." Compl.
When does ruxolitinib patent expire?
Ruxolitinib was authorized likewise by FDA in November 2011 and the US patent is expected to expire in December 2027.
When can drugs become generic?
When patent protection for a brand-name drug expires, the U.S. Food and Drug Administration can approve a generic version of it for sale. The patent protection for a brand-name drug is usually 20 years from the date of the submission of the patent.
Is eliquis going generic in 2022?
As the original manufacturers, they own a patent that prevents generics from being introduced until the patent expires. That patent was extended from February 2023 to November 2026. Both drug makers say that's when generics can be made available.
What to tell your healthcare provider before taking Jakafi?
Before taking Jakafi, tell your healthcare provider about: all the medications, vitamins, and herbal supplements you are taking and all your medical conditions, including if you have an infection, have or had low white or red blood cell counts, have or had tuberculosis (TB) or have been in close contact with someone who has TB, had shingles (herpes zoster), have or had hepatitis B, have or had liver or kidney problems, are on dialysis, have high cholesterol or triglycerides, had cancer, are a current or past smoker, had a blood clot, heart attack, other heart problems or stroke, or have any other medical condition. Take Jakafi exactly as your healthcare provider tells you. Do not change your dose or stop taking Jakafi without first talking to your healthcare provider.
What is Jakafi used for?
Jakafi is a prescription medicine used to treat adults with polycythemia vera who have already taken a medicine called hydroxyurea and it did not work well enough or they could not tolerate it.
Does Jakafi cause bruising?
The most common side effects of Jakafi include: for certain types of myelofibrosis (MF) and polycythemia vera (PV) – low platelet or red blood cell counts , bruising, dizziness, headache, and diarrhea; for acute GVHD – low platelet counts, low red or white blood cell counts, infections, and swelling; and for chronic GVHD – low red blood cell or platelet counts and infections including viral infections.
Can Jakafi cause low platelet count?
Low blood counts: Jakafi® (ruxolitinib) may cause low platelet, red blood cell, or white blood cell counts. If you develop bleeding, stop taking Jakafi and call your healthcare provider. Your healthcare provider will do a blood test to check your blood counts before you start Jakafi and regularly during your treatment. Your healthcare provider may change your dose of Jakafi or stop your treatment based on the results of your blood tests. Tell your healthcare provider right away if you develop or have worsening symptoms such as unusual bleeding, bruising, tiredness, shortness of breath, or a fever.
How often should I check my cholesterol after taking Jakafi?
Your healthcare provider will do blood tests to check your cholesterol levels about every 8 to 12 weeks after you start taking Jakafi, and as needed.
Can Jakafi cause blood clots?
Increased risk of blood clots: Blood clots in the veins of your legs (deep vein thrombosis, DVT) or lungs (pulmonary embolism, PE) have happened in people taking another JAK inhibitor for rheumatoid arthritis and may be life-threatening. Tell your healthcare provider right away if you have any signs and symptoms of blood clots during treatment with Jakafi, including: swelling, pain, or tenderness in one or both legs, sudden, unexplained chest or upper back pain, shortness of breath or difficulty breathing
Can Jakafi cause heart attacks?
Increased risk of major cardiovascular events such as heart attack, stroke or death in people who have cardiovascular risk factors and who are current or past smokers while using another JAK inhibitor to treat rheumatoid arthritis: Get emergency help right away if you have any symptoms of a heart attack or stroke while taking Jakafi, including: discomfort in the center of your chest that lasts for more than a few minutes, or that goes away and comes back, severe tightness, pain, pressure, or heaviness in your chest, throat, neck, or jaw, pain or discomfort in your arms, back, neck, jaw, or stomach, shortness of breath with or without chest discomfort, breaking out in a cold sweat, nausea or vomiting, feeling lightheaded, weakness in one part or on one side of your body, slurred speech
Can I get free Jakafi?
For insurance coverage delays, eligible patients can receive a free short-term supply of Jakafi. †
Is Jakafi compendia approved?
Valid prescription for Jakafi for an FDA-approved indication or compendia-recognized use is required. Patients insured through Medicare Part D, Medicare Advantage, Medicaid, TRICARE, or a state medical assistance program are not eligible. Free product is offered to eligible patients without any purchase contingency or other obligation.
What to tell your healthcare provider before taking Jakafi?
Before taking Jakafi, tell your healthcare provider about: all the medications, vitamins, and herbal supplements you are taking and all your medical conditions, including if you have an infection, have or had low white or red blood cell counts, have or had tuberculosis (TB) or have been in close contact with someone who has TB, had shingles (herpes zoster), have or had hepatitis B, have or had liver or kidney problems, are on dialysis, have high cholesterol or triglycerides, had cancer, are a current or past smoker, had a blood clot, heart attack, other heart problems or stroke, or have any other medical condition. Take Jakafi exactly as your healthcare provider tells you. Do not change your dose or stop taking Jakafi without first talking to your healthcare provider.
What is Jakafi used for?
Jakafi is a prescription medicine used to treat adults with polycythemia vera who have already taken a medicine called hydroxyurea and it did not work well enough or they could not tolerate it.
What is IncyteCARES for Jakafi?
IncyteCARES for Jakafi is a program designed to offer ongoing support and resources during your treatment with Jakafi. If you enrolled in IncyteCARES for Jakafi at your Healthcare Professional’s office, but did not sign the form, you can finish the last step in the enrollment process here. Enter your information in the fields below, check the authorization box, and then click Submit.
How often should I check my cholesterol after taking Jakafi?
Your healthcare provider will do blood tests to check your cholesterol levels about every 8 to 12 weeks after you start taking Jakafi, and as needed.
Does Jakafi cause bruising?
The most common side effects of Jakafi include: for certain types of myelofibrosis (MF) and polycythemia vera (PV) – low platelet or red blood cell counts , bruising, dizziness, headache, and diarrhea; for acute GVHD – low platelet counts, low red or white blood cell counts, infections, and swelling; and for chronic GVHD – low red blood cell or platelet counts and infections including viral infections.
Can Jakafi cause blood clots?
Increased risk of blood clots: Blood clots in the veins of your legs (deep vein thrombosis, DVT) or lungs (pulmonary embolism, PE) have happened in people taking another JAK inhibitor for rheumatoid arthritis and may be life-threatening. Tell your healthcare provider right away if you have any signs and symptoms of blood clots during treatment with Jakafi, including: swelling, pain, or tenderness in one or both legs, sudden, unexplained chest or upper back pain, shortness of breath or difficulty breathing
Can Jakafi cause low platelet count?
Low blood counts: Jakafi® (ruxolitinib) may cause low platelet, red blood cell, or white blood cell counts. If you develop bleeding, stop taking Jakafi and call your healthcare provider. Your healthcare provider will do a blood test to check your blood counts before you start Jakafi and regularly during your treatment. Your healthcare provider may change your dose of Jakafi or stop your treatment based on the results of your blood tests. Tell your healthcare provider right away if you develop or have worsening symptoms such as unusual bleeding, bruising, tiredness, shortness of breath, or a fever.
What to tell your healthcare provider before taking Jakafi?
Before taking Jakafi, tell your healthcare provider about: all the medications, vitamins, and herbal supplements you are taking and all your medical conditions, including if you have an infection, have or had low white or red blood cell counts, have or had tuberculosis (TB) or have been in close contact with someone who has TB, had shingles (herpes zoster), have or had hepatitis B, have or had liver or kidney problems, are on dialysis, have high cholesterol or triglycerides, had cancer, are a current or past smoker, had a blood clot, heart attack, other heart problems or stroke, or have any other medical condition. Take Jakafi exactly as your healthcare provider tells you. Do not change your dose or stop taking Jakafi without first talking to your healthcare provider.
What is jakafi used for?
Jakafi is used to treat adults with certain types of myelofibrosis.
How often should I check my cholesterol after taking Jakafi?
Your healthcare provider will do blood tests to check your cholesterol levels about every 8 to 12 weeks after you start taking Jakafi, and as needed.
Can Jakafi cause low platelet count?
Low blood counts: Jakafi® (ruxolitinib) may cause low platelet, red blood cell, or white blood cell counts. If you develop bleeding, stop taking Jakafi and call your healthcare provider. Your healthcare provider will do a blood test to check your blood counts before you start Jakafi and regularly during your treatment. Your healthcare provider may change your dose of Jakafi or stop your treatment based on the results of your blood tests. Tell your healthcare provider right away if you develop or have worsening symptoms such as unusual bleeding, bruising, tiredness, shortness of breath, or a fever.
Can Jakafi cause heart attacks?
Increased risk of major cardiovascular events such as heart attack, stroke or death in people who have cardiovascular risk factors and who are current or past smokers while using another JAK inhibitor to treat rheumatoid arthritis: Get emergency help right away if you have any symptoms of a heart attack or stroke while taking Jakafi, including: discomfort in the center of your chest that lasts for more than a few minutes, or that goes away and comes back, severe tightness, pain, pressure, or heaviness in your chest, throat, neck, or jaw, pain or discomfort in your arms, back, neck, jaw, or stomach, shortness of breath with or without chest discomfort, breaking out in a cold sweat, nausea or vomiting, feeling lightheaded, weakness in one part or on one side of your body, slurred speech
Does Jakafi help with cancer?
Cancer: Some people have had certain types of non-melanoma skin cancers during treatment with Jakafi. Your healthcare provider will regularly check your skin during your treatment with Jakafi. Tell your healthcare provider if you develop any new or changing skin lesions during treatment with Jakafi.
Can Jakafi cause a fever?
Infection: You may be at risk for developing a serious infection during treatment with Jakafi. Tell your healthcare provider if you develop any of the following symptoms of infection: chills, nausea, vomiting, aches, weakness, fever, painful skin rash or blisters.
What is the PAP number for Jakafi?
For more information, call IncyteCARES at 1-855-452-5234, Monday through Friday, 8 am –8 pm ET. The IncyteCARES Patient Assistance Program (PAP) helps eligible patients who do not have prescription drug insurance or who have trouble affording their copay for Jakafi. No purchase contingencies or other obligations apply.
What is Jakafi used for?
Jakafi is indicated for treatment of steroid-refractory acute graft-versus-host disease (aGVHD) in adult and pediatric patients 12 years and older .
How long does it take for myelofibrosis to return after Jakafi?
When discontinuing Jakafi, myeloproliferative neoplasm-related symptoms may return within one week. After discontinuation, some patients with myelofibrosis have experienced fever, respiratory distress, hypotension, DIC, or multi-organ failure. If any of these occur after discontinuation or while tapering Jakafi, evaluate and treat any intercurrent illness and consider restarting or increasing the dose of Jakafi. Instruct patients not to interrupt or discontinue Jakafi without consulting their physician. When discontinuing or interrupting Jakafi for reasons other than thrombocytopenia or neutropenia, consider gradual tapering rather than abrupt discontinuation
What are the most common nonhematologic adverse reactions in myelofibrosis?
In myelofibrosis and polycythemia vera, the most common nonhematologic adverse reactions (incidence ≥15%) were bruising, dizziness, headache, and diarrhea. In acute graft-versus-host disease, the most common nonhematologic adverse reactions (incidence >50%) were infections (pathogen not specified) and edema. In chronic graft-versus-host disease, the most common nonhematologic adverse reactions (incidence ≥20%) were infections (pathogen not specified) and viral infections
Can you take jakafi for TB?
Tuberculosis (TB) infection has been reported. Observe patients taking Jakafi for signs and symptoms of active TB and manage promptly. Prior to initiating Jakafi, evaluate patients for TB risk factors and test those at higher risk for latent infection. Consult a physician with expertise in the treatment of TB before starting Jakafi in patients with evidence of active or latent TB. Continuation of Jakafi during treatment of active TB should be based on the overall risk-benefit determination
How much of FPL is eligible for Medicare Part D?
OR. Medicare Part D patients may be eligible by meeting additional criteria and program requirements, including but not limited to earning less than 600% of the FPL. HOW TO ENROLL YOUR PATIENTS.
Can Jakafi be taken with fluconazole?
Avoid concomitant use with fluconazole doses greater than 200 mg. Dose modifications may be required when administering Jakafi with fluconazole doses of 200 mg or less , or with strong CYP3A4 inhibitors, or in patients with renal or hepatic impairment. Patients should be closely monitored and the dose titrated based on safety and efficacy
What is Jakafi used for?
Jakafi (ruxolitinib) is a member of the multikinase inhibitors drug class and is commonly used for Graft-versus-host disease, Myelofibrosis, Myeloproliferative Disorders, and others.
How much does Jakafi cost?
The cost for Jakafi oral tablet 5 mg is around $15,413 for a supply of 60 tablets, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
Is Jakafi covered by insurance?
Jakafi Temporary Coverage: Eligible commercially insured patients may receive a supply of medication for FREE if they are experiencing a delay in their insurance coverage; for additional information contact the program at 855-452-5234.
Is Jakafi a brand name?
Jakafi is available as a brand name drug only, a generic version is not yet available. For more information, read about generic Jakafi availability .
